WO2025133221 - A METHOD FOR CCI TESTING
National phase entry is expected:
Publication Number
WO/2025/133221
Publication Date
26.06.2025
International Application No.
PCT/EP2024/088058
International Filing Date
20.12.2024
Title **
[English]
A METHOD FOR CCI TESTING
[French]
PROCÉDÉ D'ESSAI CCI
Applicants **
NOVO NORDISK A/S
Inventors
CABAÑEROS LÓPEZ, Pau
KUNOV-KRUSE, Andreas, Jonas
STAPPEN, Frederick
WANG, Jinyuhan
Priority Data
23219115.5
21.12.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2032 | |
| EPO | Filing, Examination, Granting | 8126 | |
| Japan | Filing, Examination, Granting | 2155 | |
| South Korea | Filing, Examination, Granting | 2071 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,124
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention provides a method of testing container closure integrity which comprises (i) subjecting a container (10, 30) comprising a transparent wall portion (11, 31) and a drug chamber (17, 37) holding a liquid drug to a test environment (2) comprising a test gas with pH changing capabilities over a period of time sufficient to allow dissolution of any test gas from the test environment (2) in the liquid drug, (ii) combining at least a portion of the liquid drug with a pH indicator, and (iii) determining a presence or absence of dissolved test gas in the drug chamber (17, 37) from a protonation state of the pH indicator.[French]
La présente invention concerne un procédé d'essai d'intégrité de fermeture de récipient qui comprend (i) la soumission d'un récipient (10, 30) comprenant une partie de paroi transparente (11, 31) et une chambre de médicament (17, 37) contenant un médicament liquide à un environnement d'essai (2) comprenant un gaz d'essai ayant des capacités de changement de pH sur une période de temps suffisante pour permettre la dissolution d'un gaz d'essai quelconque provenant de l'environnement d'essai (2) dans le médicament liquide, (ii) la combinaison d'au moins une partie du médicament liquide avec un indicateur de pH, et (iii) la détermination de la présence ou de l'absence de gaz d'essai dissous dans la chambre de médicament (17, 37) à partir d'un état de protonation de l'indicateur de pH.